MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial
Conditions
Interventions
- DRUG: MDCO-216
- DRUG: Placebo
Sponsor
The Medicines Company
Collaborators